All episodes
Understanding Physical Exam Findings Associated With FND - Part 1
Environmental Toxicants and Parkinson Disease
Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2
Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1
Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1
The Temporal Order of Genetic, Environmental, and Pathological Risk Factors in Parkinson Disease
Headache Medicine and Women's Health Series: Migraine Screening and ID Migraine Tool
Neural Synaptic Vesicle Autoimmunity Following Aerosolized Porcine Neural Tissue Exposure - Part 2
Neural Synaptic Vesicle Autoimmunity Following Aerosolized Porcine Neural Tissue Exposure - Part 1
Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults - Part 2
Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults - Part 2
Using Neurofilament Light Chain in Clinical Practice
Headache Medicine and Women's Health Series: Overview of Menstrual Migraine
Levetiracetam - Part 2
Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults - Part 1
Multiple System Atrophy Without Dysautonomia
Levetiracetam - Part 1
Headache Medicine and Women's Health Series: Menstrual Migraine
January 2026 President Spotlight: What to Expect in 2026
The Core Identity of the Neurologist
Deep Learning Modeling to Differentiate MS From MOGAD
Candesartan for Migraine Prevention
Gait Improvement Following Cerebrospinal Fluid Tap Test in NPH Patients - Part 2
Gait Improvement Following Cerebrospinal Fluid Tap Test in NPH Patients - Part 1
Management of Functional Seizures Practice Guideline Executive Summary
The Growing Need for Preventive Neurologists
Functional Neurologic Disorder Series - Part 7
Functional Neurologic Disorder Series - Part 6
Functional Neurologic Disorder Series - Part 5
Clinical Reasoning: A 35-Year-Old Woman With Personality Change and Gait Impairment
Functional Neurologic Disorder Series - Part 4
Functional Neurologic Disorder Series - Part 3
Highlights From the 2025 World Stroke Congress - Part 2
Targeting Self-Described Knowledge Gaps to Improve FND Education among Clinicians - Part 2
Challenges and Opportunities in Diagnosing CRAO/BRAO
Highlights From the 2025 World Stroke Congress - Part 1
Functional Neurologic Disorder Series - Part 2
Functional Neurologic Disorder Series - Part 1
Primary Progressive Aphasia - Part 5
Traumatic Encephalopathy Syndrome in the LETBI Study Cohort
Targeting Self-Described Knowledge Gaps to Improve FND Education among Clinicians - Part 1
December President Spotlight: A Year in Review
Primary Progressive Aphasia - Part 4
Primary Progressive Aphasia - Part 3
Screening for Congenital Myasthenic Syndromes in Adults With Seronegative MG
Executive Function Deficits in Genetic Frontotemporal Dementia
Primary Progressive Aphasia - Part 2
Primary Progressive Aphasia - Part 1
Women History Minute - Sylvia Lawry
Dementia with Lewy Bodies and Parkinson Disease Dementia
Outcomes After RCVS With Convexity Subarachnoid Hemorrhage
November President Spotlight: Medicare 2026 Rulemaking
Safety and Efficacy of Nipocalimab in Adults With Generalized Myasthenia Gravis (Vivacity-MG3)
Interpreting Cerebrospinal Fluid in the 2024 McDonald Criteria Revisions
Women History Minute - Marcelle Lapicque
Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication
Prodromal Phase of Migraine - Part 2
Prodromal Phase of Migraine - Part 1
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 2
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 1
Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies
Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 3
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 2
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 1
Persistent Postictal Central Apnea in Focal Seizures
Association Between Consumption of Artificial Sweeteners With Cognitive Decline
Oropouche Virus
Multiple Sclerosis Imaging Biomarkers - Part 2
Multiple Sclerosis Imaging Biomarkers - Part 1
Trends in Prenatal Exposure to Antiseizure Medications
Overview from the 2025 Alzheimer's Association International Conference
Proximity to Golf Courses and Risk of Parkinson Disease
Evolving Insights into the Diagnosis, Management, and Outcomes of PRES - Part 2
Evolving Insights into the Diagnosis, Management, and Outcomes of PRES - Part 1
Lifestyle Interventions for Global Cognitive Function
TOAST Criteria: Time is Brain, or Brain is TOAST – Part 2
TOAST Criteria: Time is Brain, or Brain is TOAST – Part 1
Measles - Part 5
Measles - Part 4
Updates in Idiopathic Intracranial Hypertension
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
October 2025 President Spotlight: Critical Importance of Research
October 2025 Capitol Hill Report: Government Shutdown
WHO Launches New Technical Brief on Encephalitis - Part 2
WHO Launches New Technical Brief on Encephalitis - Part 1
Measles - Part 3
Measles - Part 3
Measles - Part 2
Measles - Part 1
September 2025 Capitol Hill Report: BrainPAC Update
Overcoming Colonialism in Pathogen Genomics
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 2
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 1
Outcomes Following Acute Plasma Exchange for MOGAD - Part 3
Outcomes Following Acute Plasma Exchange for MOGAD - Part 2
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
Outcomes Following Acute Plasma Exchange for MOGAD - Part 1
Safety and Efficacy of Satralizumab in Patients with Generalized MG